A detailed history of Howard Capital Management Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Howard Capital Management Group, LLC holds 731 shares of LLY stock, worth $668,550. This represents 0.04% of its overall portfolio holdings.

Number of Shares
731
Previous 731 -0.0%
Holding current value
$668,550
Previous $426,000 33.33%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

SELL
$525.19 - $619.13 $26,259 - $30,956
-50 Reduced 6.4%
731 $426,000
Q2 2023

Aug 16, 2023

SELL
$350.74 - $468.98 $127,318 - $170,239
-363 Reduced 31.73%
781 $366,000
Q1 2023

Apr 20, 2023

BUY
$310.63 - $364.82 $60,883 - $71,504
196 Added 20.68%
1,144 $392,000
Q4 2021

Jan 19, 2022

BUY
$224.85 - $279.04 $10,343 - $12,835
46 Added 5.1%
948 $262,000
Q3 2021

Oct 25, 2021

BUY
$221.6 - $272.71 $199,883 - $245,984
902 New
902 $208,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Howard Capital Management Group, LLC Portfolio

Follow Howard Capital Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Capital Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howard Capital Management Group, LLC with notifications on news.